Cost-effectiveness Analysis Of Idursulfase For The Treatment Of Hunter Syndrome In A Tertiary Referral Centre For Rare Diseases In Malaysia: A Partitioned Survival Model Approach
Hunter syndrome (MPS-II) is among the costliest life-long genetic conditions associated with a substantial burden of illness and its significant impact on Malaysia's health systems, families, and society. There needs to be more studies demonstrating its value for money incorporating long-term e...
| 第一著者: | |
|---|---|
| フォーマット: | 学位論文 |
| 言語: | 英語 |
| 出版事項: |
2024
|
| 主題: | |
| オンライン･アクセス: | http://eprints.usm.my/62056/ |